These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25546414)

  • 1. Biochemical markers, liver biopsy, or magnetic resonance elastography to detect or exclude advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Kayadibi H; Sertoglu E; Uyanik M
    Hepatology; 2015 Jul; 62(1):324-5. PubMed ID: 25546414
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.
    Wong VW; Vergniol J; Wong GL; Foucher J; Chan HL; Le Bail B; Choi PC; Kowo M; Chan AW; Merrouche W; Sung JJ; de Lédinghen V
    Hepatology; 2010 Feb; 51(2):454-62. PubMed ID: 20101745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease.
    Alisi A; Pinzani M; Nobili V
    Hepatology; 2009 Dec; 50(6):2048-9; author reply 2049-50. PubMed ID: 19937689
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E; Lee TP
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
    Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V
    Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy?
    Yoon JH; Lee JM; Suh KS; Lee KW; Yi NJ; Lee KB; Han JK; Choi BI
    Radiology; 2015 Aug; 276(2):453-64. PubMed ID: 25763828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases.
    Ochi H; Hirooka M; Koizumi Y; Miyake T; Tokumoto Y; Soga Y; Tada F; Abe M; Hiasa Y; Onji M
    Hepatology; 2012 Oct; 56(4):1271-8. PubMed ID: 22488593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.
    Nobili V; Vizzutti F; Arena U; Abraldes JG; Marra F; Pietrobattista A; Fruhwirth R; Marcellini M; Pinzani M
    Hepatology; 2008 Aug; 48(2):442-8. PubMed ID: 18563842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.
    Cui J; Heba E; Hernandez C; Haufe W; Hooker J; Andre MP; Valasek MA; Aryafar H; Sirlin CB; Loomba R
    Hepatology; 2016 Feb; 63(2):453-61. PubMed ID: 26560734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.
    Thavorn K; Coyle D
    Ont Health Technol Assess Ser; 2015; 15(19):1-58. PubMed ID: 26664666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Science to practice: can MR elastography be used to detect early steatohepatitis in fatty liver disease?
    Ehman RL
    Radiology; 2009 Oct; 253(1):1-3. PubMed ID: 19789246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.
    Golabi P; Sayiner M; Fazel Y; Koenig A; Henry L; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):63-71. PubMed ID: 26469309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy.
    Myers RP; Crotty P; Pomier-Layrargues G; Ma M; Urbanski SJ; Elkashab M
    Liver Int; 2010 Nov; 30(10):1471-80. PubMed ID: 20807336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of Noninvasive Measures of Liver Fibrosis Into Clinical Practice: Diagnosis and Prognosis.
    Asrani SK
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2190-204. PubMed ID: 26226095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.
    Brener S
    Ont Health Technol Assess Ser; 2015; 15(18):1-45. PubMed ID: 26664664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.